Keryx Biopharmaceuticals, Inc.

Q4 2013 vs. Q3 2018 13F Holders

Period
Q4 2013
Q3 2018
Num holders
145
142
Total reported value, excl. options
$661 M
$263 M
Total shares, excl. options
51,032,848
77,195,929
Manager Q4 2013
Shares 		Q3 2018
Shares 		Diff Chg %